<html>
<head>PUBMED IDs for BHC80</head>
<body bgcolor='#C5F0F2'><h1>BHC80</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12032298/'>A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes.</a> May 29  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15325272/'>Characterization of BHC80 in BRAF-HDAC complex, involved in neuron-specific gene repression.</a> August 25  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16140033/'>Regulation of LSD1 histone demethylase activity by its associated factors.</a> September 6  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16684532/'>A component of BRAF-HDAC complex, BHC80, is required for neonatal survival in mice.</a> May 11  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17687328/'>Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression.</a> August 10  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19439607/'>The rest repression of the neurosecretory phenotype is negatively modulated by BHC80, a protein of the BRAF/HDAC complex.</a> May 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22770980/'>Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies.</a> September 21  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25639869/'>HMG20A is required for SNAI1-mediated epithelial to mesenchymal transition.</a> January 9  2015<br></body></html>
